Market Insights Health Pharmaceuticals Vaccines

Other Vaccines - Peru

Peru

In Peru, the revenue in the market of Other Vaccines market is predicted to reach US$55.17m in 2024.
It is anticipated that the revenue will exhibit an annual growth rate (CAGR 2024-2029) of 10.33%, leading to a market volume of US$90.20m by 2029.
When compared on a global scale, United States is projected to generate the highest revenue with US$24,730.00m in 2024.
Peru is witnessing a growing demand for other vaccines, driven by increasing awareness and government initiatives to improve public health.

Key regions: Australia, Brazil, United Kingdom, Europe, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The Other Vaccines market in Peru has been experiencing steady growth in recent years.

Customer preferences: Peruvian customers have shown an increased interest in preventative healthcare, leading to a rise in demand for vaccines. The government has also been promoting vaccination campaigns, which has further boosted the demand for vaccines in the country.

Trends in the market: One of the major trends in the Other Vaccines market in Peru is the growing popularity of travel vaccines. With more Peruvians traveling abroad for business and leisure, there has been an increased demand for vaccines that protect against diseases prevalent in other countries. Another trend is the increased availability of vaccines in pharmacies and private clinics, making it easier for customers to access vaccines outside of traditional healthcare settings.

Local special circumstances: Peru has a diverse population with varying healthcare needs, and this has led to the development of specialized vaccines to meet these needs. For example, vaccines have been developed to protect against diseases that are more prevalent in certain regions of Peru, such as yellow fever and dengue fever. Additionally, the country has a large indigenous population, and efforts have been made to provide vaccines that are culturally appropriate and accessible to these communities.

Underlying macroeconomic factors: Peru's growing economy has led to an increase in disposable income, allowing more people to afford preventative healthcare measures such as vaccines. Additionally, the government has been investing in healthcare infrastructure, making it easier for people to access healthcare services including vaccines. The country's geographic location also plays a role, as Peru is situated in an area with a high prevalence of infectious diseases, making vaccines an important part of public health efforts.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.